Health
Kratom to Be Tested for Addiction Risk in First-Ever Study
This article is for subscribers only.
Popular for its stimulating and pain-relieving properties, the herb kratom can be as easy to buy as a bag of chips in many parts of the US. That’s also raised questions about whether kratom should be more closely regulated.
A new US Food and Drug Administration-funded clinical trial expected to begin this summer seeks to provide more insight into kratom’s potential for abuse by comparing the leaf’s draw to that of the addictive opioid oxycodone.